Table 2.
Per-case monetary estimates of each health end point (Shea et al. 2020).
| Study basis | Health end point | Cost of illness definition | Unit value (2015$) |
|---|---|---|---|
| PTB | |||
| Institute of Medicine Committee on Understanding Premature Birth and Assuring Healthy Outcomes 2007 | Any PTB | , 3% discount rate (DR) | 70,101 |
| LBW | |||
| Russell et al. 2007 | LBW among those with slow growth/malnutrition | Initial hospital costs | 15,560 |
| ASD | |||
| Buescher et al. 2014 | ASDs with intellectual disability | , 3% DR | 3,109,096 |
| ASDs without intellectual disability | , 3% DR | 1,805,941 | |
| Asthma | |||
| Nurmagambetov et al. 2018 | Age 3 y onset, no persistence into adulthood | , 3% DR | 23,573 |
| Age 3 y onset, persistence into adulthood | , 3% DR | 91,954 | |
Note: The values for asthma and ASD include high and low values. For asthma this is related to whether or not there is a persistence of the disorder into adulthood. For ASD this is related to whether there is an intellectual disability or not. For these end points, both the high and low per-case monetary estimate values were used, and the results are reported as a range. ASD, autism spectrum disorder; LBW, low birth weight; PTB, preterm birth.